Purpose: The goal of this study was to assess the proportion of hypertensive patients who had 1 or more of the following major modifiable cardiovascular risk factors: dyslipidemia, metabolic syndrome, diabetes, current smoking and overweight. Material and Methods: A total of 650 individuals, aged between 20–80 years with a positive diagnosis of arterial hypertension were enrolled in our prospective epidemiological study in 2006. The follow up period lasted for 3 years. Data collection was conducted in local county hospital in the participant's residential area. During the study visit, we administered a standardized questionnaire which assessed: age, sex, education, cigarette smoking, myocardial infarction, congestive heart failure and the previous diagnosis and treatment of hypertension, high cholesterol, and diabetes. Descriptive statistics (SPSS 17) for categorical variables were used for the study cohort. Results: 328 women and 322 men were available for analysis. 50,37% of patients had been diagnosed with high blood pressure for more than 10 years, 21,84% had HT between 5 to 10 years and 19,53% had a positive diagnosis of HT between 2 to 5 years. The prevalence of the risk factors in study population was: 14,30%, 14,30%, and 13,53% of men and 13,38%, 14%, and 16,46% of women had 1, 2, and 3 of these risk factors, respectively. We also assessed the prevalence of individual metabolic syndrome (MS) components and number of fulfilled components. MS was present in 268 subjects (41,23%) according to the NCEP-ATP III definition. The prevalence of the metabolic syndrome was higher in women (21,23%) compared with men (20%). Conclusions: Arterial hypertension is a major cause of cardiovascular morbidity and mortality in our area. Overall, 72,31% of hypertensive patients have at least 1 cardiovascular risk factor from the 7 cardiovascular risk factors assessed in the current study. Effective population-based interventions such as smoking cessation, improved diet, and increased physical activity can safely and effectively lower the risk of cardiovascular morbidity’ and mortality.